Specific concentration limit as a tool for classifying mixtures by human health hazards. Part 2. Methods of determination: A systematic review
D.S. Valuyeu
Avrora Production Complex LLP., 401-40 Maskeu Str., Astana, Z10X5D6, Republic of Kazakhstan
The work is a systematic review focused on analyzing methods for determining specific concentration limits (SCL) for chemicals hazardous to human health.
The literature search was conducted up to November 2024 in the electronic databases PubMed, Google Scholar, and CyberLeninka, and up to April 2025 in ScienceDirect and eLIBRARY.RU. Outside the scope of the systematic review, the possibility of determining SCL using alternative methods (AM) described in OECD standards was analyzed for substances cor-rosive/irritating to skin, able to cause serious eye damage/irritation, or skin sensitizers.
The review included publications in Russian and English describing experimental and calculation approaches to es-tablishing SCL. Studies related to waste were excluded. Screening and assessment of publications were performed by a single author; data synthesis was descriptive.
A total of 14 studies were included in the systematic review. No methods for determining SCL were identified for respiratory sensitizers and mutagens. For substances causing skin corrosion/irritation, serious eye damage/irritation, and for skin sensitizers, current regulatory practice relies on in vivo approaches and human data. To reduce the number of laboratory animals and optimize the procedure for establishing SCL for substances corrosive/irritating to skin and eyes, the author proposed a basic concentration range (BCR) designed to enable more efficient use of AM.
For skin sensitizers, carcinogens, and reproductive toxicants, SCL are determined based on toxicant potency and hazard (sub)class, which may complicate the implementation of a similar approach in the EAEU. Moreover, the numerical descriptor ranges used for substance categorization are often based on expert consensus.
The review did not include publications in other languages or those from paid-access databases; quantitative synthesis was not conducted due to the qualitative nature of the data.
This work identified critical gaps in the existing methods for determining SCL, highlighting the need developing and validating new test systems suitable for integration into regulatory practice.
- Valuyeu D.S. Specific concentration limit as a tool for classifying mixtures by human health hazards. Part 1. Charac-teristics, scope, regulatory aspects of implementation in the EAEU. Health Risk Analysis, 2025, no. 1, pp. 16–23. DOI: 10.21668/health.risk/2025.1.02.eng
- Page M.J., Moher D., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M. [et al.]. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ, 2021, vol. 372, pp. n160. DOI: 10.1136/bmj.n160
- Page M.J., McKenzie J.E., Bossuyt P.M., Boutron I., Hoffmann T.C., Mulrow C.D., Shamseer L., Tetzlaff J.M. [et al.]. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ, 2021, vol. 372, pp. n71. DOI: 10.1136/bmj.n71
- Basketter D.A., Andersen K.E., Liden C., Van Loveren H., Boman A., Kimber I., Alanko K., Berggren E. Evaluation of the skin sensitizing potency of chemicals by using the existing methods and considerations of relevance for elicitation. Contact Dermatitis, 2005, vol. 52, no. 1, pp. 39–43. DOI: 10.1111/j.0105-1873.2005.00490.x
- Schneider K., Akkan Z. Quantitative relationship between the local lymph node assay and human skin sensitization as-says. Regul. Toxicol. Pharm., 2004, vol. 39, no. 3, pp. 245–255. DOI: 10.1016/j.yrtph.2004.02.002
- Sawyer C., Peto R., Bernstein L., Pike M.C. Calculation of carcinogenic potency from long-term animal carcinogenesis experiments. Biometrics, 1984, vol. 40, no. 1, pp. 27–40.
- Sanner T., Dybing E., Kroese D., Roelfzema H., Hardeng S. Potency grading in carcinogen classification. Mol. Car-cinog., 1997, vol. 20, no. 3, pp. 280–287. DOI: 10.1002/(sici)1098-2744(199711)20:33.0.co;2-p
- Dybing E., Sanner T., Roelfzema H., Kroese D., Tennant R.W. T25: a simplified carcinogenic potency index: description of the system and study of correlations between carcinogenic potency and species/site specificity and mutagenicity. Pharmacol. Toxicol., 1997, vol. 80, no. 6, pp. 272–279. DOI: 10.1111/j.1600-0773.1997.tb01973.x
- Roberts R.A., Crump K.S., Lutz W.K., Wiegand H.J., Williams G.M., Harrison P.T., Purchase I.F. Scientific analysis of the proposed uses of the T25 dose descriptor in chemical carcinogen regulation. Arch. Toxicol., 2001, vol. 75, no. 9, pp. 507–512. DOI: 10.1007/s002040100271
- Sanner T., Dybing E., Willems M.I., Kroese E.D. A simple method for quantitative risk assessment of non-threshold carcinogens based on the dose descriptor T25. Pharmacol. Toxicol., 2001, vol. 88, no. 6, pp. 331–341.
- Van Landingham C.B., Allen B.C., Shipp A.M., Crump K.S. Comparison of the EU T25 single point estimate method with benchmark dose response modeling for estimating potency of carcinogens. Risk Anal., 2001, vol. 21, no. 4, pp. 641–656. DOI: 10.1111/0272-4332.214141
- European Food Safety Authority (EFSA). EFSA/WHO International Conference with support of ILSI Europe on Risk Assessment of Compounds that are both Genotoxic and Carcinogenic. EFSA Supporting Publications, 2006, vol. 3, no. 2, 290 p. DOI: 10.2903/sp.efsa.2006.EN-92
- Hennes C., Batke M., Bomann W., Duhayon S., Kosemund K., Politano V., Stinchcombe S., Doe J. Incorporating po-tency into EU classification for carcinogenicity and reproductive toxicity. Regul. Toxicol. Pharmacol., 2014, vol. 70, no. 2, pp. 457–467. DOI: 10.1016/j.yrtph.2014.07.022
- Muller A., Blaude M.-N., Ihlemann C., Bjorge C., Ohlsson A., Gebel T. A regulatory approach to assess the potency of substances toxic to the reproduction. Regul. Toxicol. Pharmacol., 2012, vol. 63, no. 1, pp. 97–105. DOI: 10.1016/j.yrtph.2012.02.012
- Fraser S., Garcia M.M., Mason H., Wilday J. COMAH 2015: Practical classification of mixtures on COMAH estab-lishments. Hazards 26, 2016, Symposium series No. 161. Available at: https://www.icheme.org/media/11760/hazards-26-paper-23-comah-2015-practi... (October 02, 2025).
- Young J.R., How M.J., Walker A.P., Worth W.M. Classification as corrosive or irritant to skin of preparations containing acidic or alkaline substances, without testing on animals. Toxicol. In Vitro, 1988, vol. 2, no. 1, pp. 19–26. DOI: 10.1016/0887-2333(88)90032-x
- Valuyeu D.S. pH and reserve acidity (alkalinity) in the toxicological evaluation of chemicals: problems and solutions. Chemical Safety Science, 2024, vol. 8, no. 2, pp. 220–234. DOI: 10.25514/CHS.2024.2.27008 (in Russian).
- Worth A.P., Cronin M.T. The use of pH measurements to predict the potential of chemicals to cause acute dermal and ocular toxicity. Toxicology, 2001, vol. 169, no. 2, pp. 119–131. DOI: 10.1016/s0300-483x(01)00494-2
- Draft detailed review paper to facilitate the development of test methods to predict the respiratory sensitization potential of low molecular weight chemicals. OECD, 2025, 126 p. Available at: https://www.oecd.org/content/dam/oecd/en/events/public-consultations/202... (October 02, 2025).
- Api A.M., Parakhia R., O’Brien D., Basketter D.A. Fragrances categorized according to relative human skin sensiti-zation potency. Dermatitis, 2017, vol. 28, no. 5, pp. 299–307. DOI: 10.1097/DER.0000000000000304
- Natsch A., Haupt T., Wareing B., Landsiedel R., Kolle S.N. Predictivity of the kinetic direct peptide reactivity assay (kDPRA) for sensitizer potency assessment and GHS subclassification. ALTEX, 2020, vol. 37, no. 4, pp. 652–664. DOI: 10.14573/altex.2004292
- Natsch A., Gerberick G.F. Integrated skin sensitization assessment based on OECD methods (I): Deriving a point of departure for risk assessment. ALTEX, 2022, vol. 39, no. 4, pp. 636–646. DOI: 10.14573/altex.2201141
- Lee I., Na M., Lavelle M., Schember I., Ryan C., Gerberick G.F., Natsch A., Api A.M. Predicting points of departure and potency categories for fragrance ingredients by integrating OECD in vitro models. Food Chem. Toxicol., 2024, vol. 193, pp. 114998. DOI: 10.1016/j.fct.2024.114998
- Natsch A., Emter R., Haupt T., Ellis G. Deriving a no expected sensitization induction level for fragrance ingredients without animal testing: an integrated approach applied to specific case studies. Toxicol. Sci., 2018, vol. 165, no. 1, pp. 170–185. DOI: 10.1093/toxsci/kfy135
- Roberts D.W. A critical review of the kinetic direct peptide reactivity assay (kDPRA) for skin sensitizer potency as-sessment – taking it forward. Crit. Rev. Toxicol., 2021, vol. 51, no. 10, pp. 805–819. DOI: 10.1080/10408444.2021.2020212
- Roberts D.W. Peptide reactivity assays for skin sensitization – scope and limitations. Crit. Rev. Toxicol., 2022, vol. 52, no. 6, pp. 420–430. DOI: 10.1080/10408444.2022.2111252
- Takenouchi O., Fukui S., Okamoto K., Kurotani S., Imai N., Fujishiro M., Kyotani D., Kato Y. [et al.]. Test battery with the human cell line activation test, direct peptide reactivity assay and DEREK based on a 139 chemical data set for predicting skin sensitizing potential and potency of chemicals. J. Appl. Toxicol., 2015, vol. 35, no. 11, pp. 1318–1332. DOI: 10.1002/jat.3127
- Strickland J., Zang Q., Paris M., Lehmann D.M., Allen D., Choksi N., Matheson J., Jacobs A. [et al.]. Multivariate models for prediction of human skin sensitization hazard. J. Appl. Toxicol., 2017, vol. 37, no. 3, pp. 347–360. DOI: 10.1002/jat.3366
- Jaworska J., Dancik Y., Kern P., Gerberick F., Natsch A. Bayesian integrated testing strategy to assess skin sensitiza-tion potency: from theory to practice. J. Appl. Toxicol., 2013, vol. 33, no. 11, pp. 1353–1364. DOI: 10.1002/jat.2869
- Menz J., Götz M.E., Gündel U., Gürtler R., Herrmann K., Hessel-Pras S., Kneuer C., Kolrep F. [et al.]. Genotoxicity assessment: opportunities, challenges and perspectives for quantitative evaluations of dose-response data. Arch. Toxicol., 2023, vol. 97, no. 9, pp. 2303–2328. DOI: 10.1007/s00204-023-03553-w

fcrisk.ru

